MediPoint: Total Hip Replacement - Global Analysis and Market Forecasts

Summary

Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, this is an indication that is growing rapidly with the hip being one of the most common joints afflicted. While the primary indication for total hip replacement (THR) is osteoporosis, the other major indications for THR are osteonecrosis and fractures to a lesser degree. As people live longer and with younger patients also receiving implants, the revision rates for primary hip replacements are also expected to rise. Primary hip replacement has become one of the most successful surgeries, with a variety of femoral and acetabular components available from a wide selection of manufacturers. This report focuses on the total primary hip replacement market along with primary revision market. The global hip replacement market has been estimated in this report which includes the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compounded annual growth rates (CAGR).


GlobalData’s analysis shows that the hip replacement market has become a mature market where products have become commodities. The future of the market lays on the ability of manufacturers to provide implants at a very low cost while continuing to provide the same level of clinical efficacy. The product development need lies primarily in revising the resurfacing products’ articulating surface with new materials rather than developing new acetabular and femoral components. Additionally the major opportunity lies within the emerging markets which are the countries that have a higher CAGR and will provide the key for growth and grabbing market share.

Highlights

Key Questions Answered

- Osteoarthritis prevalence is expected to increase during the forecast period.(Q). What is the cost of osteoarthritis? (Q). How will changing demographics and lifestyles affect the incidence of hip osteoarthritis?
- THR has become one of the most accepted and successful surgeries performed. There was as a result an explosion of growth in the early years in the number of procedures and it now has become a more mature market. (Q).Will the market continue to grow and what are the drivers? (Q).Have the indications changed and are procedural numbers growing proportionately to market size?
- Resurfacing was a technology that started to replace primary THR though was quickly stopped due to metal on metal problems. (Q).What are the future trends and are there new technologies emerging in the major markets? (Q). If THR is to remain the primary mode of treating osteoarthritis, what are the types of products used and what are the market opportunities?
- There are Asian manufacturers entering the US market looking to grab market share in the US and EU. (Q).What is the Scope for more hip innovation and/ or low cost manufacturers to steal market share from the large players?
- Today there is a constant new release of pipeline product in the THR space. Current prosthesis design has exceeded expectations and performed well. (Q). What are the next developments and set of unmet needs that need to be addressed? (Q).Which countries expect to see the most adoption and what are the hurdles? (Q).How can device manufacturers differentiate themselves from the competition?

Scope

- Overview of symptomatic hip osteoarthritis, including epidemiology, diagnosis, pathology, conservative treatment techniques and surgical interventions.
- Annualized Total Hip Replacement and Revision market revenue, annual cost of the device, and procedure volume data from 2010-2012 and forecast for seven years to 2019.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, and implications for the hip replacement and replacement market.
- Pipeline analysis: Coverage of total hip replacements that are currently under research and development or under investigation.
- Analysis of the current and future market competition in the global total hip replacement and revision market. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Orthopedic Hip Surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table Of Contents

Table of Contents

1 Table of Contents 7
1.1 List of Tables 16
1.2 List of Figures 27
2 Introduction 32
2.1 Catalyst 33
2.2 Related Reports 34
2.3 Upcoming Related Reports 34
3 Disease Overview 35
3.1 Anatomy and Physiology 35
3.2 Pathophysiology 36
3.2.1 Overview 36
3.2.2 Osteoarthritis 37
3.2.3 Rheumatoid Arthritis 37
3.2.4 Post-traumatic Arthritis 38
3.2.5 Osteonecrosis 38
3.2.6 Injury 39
3.2.7 Bone Tumors 39
3.2.8 Other Diseases 39
3.3 Clinical Presentation 40
3.4 Clinical Outcomes 41
3.4.1 Overview 41
3.4.2 Conservative Therapy 43
3.4.3 Hip Arthroscopy 43
3.4.4 Hip Arthrodesis 44
3.4.5 Hemiarthroplasty (Partial) 45
3.4.6 Core Decompression 45
3.4.7 Hip Osteotomy 46
3.4.8 Resection Arthroplasty 46
3.4.9 Primary Total Hip Replacement 47
3.4.10 Revision Total Hip Replacement 49
3.4.11 Resurfacing Arthroplasty 50
3.4.12 Computer-Navigated Hip Replacement 51
3.5 Surgical Approaches 51
3.5.1 Anterolateral Approach 53
3.5.2 Posterior Approach 53
3.5.3 Direct Anterior Approach 54
3.5.4 Minimally Invasive Approaches 55
3.6 Epidemiology 55
3.6.1 US 57
3.6.2 EU 58
3.6.3 APAC 59
3.6.4 South America 61
3.7 Economic Impact 62
3.7.1 US 63
3.7.2 EU 64
3.7.3 APAC 66
3.7.4 South America 67
4 Competitive Assessment 68
4.1 Overview of Historical Designs 68
4.2 Marketed Products 69
4.2.1 Global Market Share 69
4.2.2 Primary Total Hip Replacement 72
4.2.3 Product Profiles by Company 73
5 Unmet Needs 213
5.1 Long-Term Clinical Data 213
5.2 Need for Continued Materials Research 213
5.3 Bearings 215
5.4 Refocus of Pipeline Products 216
5.5 Renewal of Resurfacing 217
5.6 Addressing the Learning Curve for Tier II Surgeons 218
5.7 Need for Cost Containment 220
5.8 Centralization 221
5.9 National Joint Registry 221
6 Pipeline Products 223
6.1 Overview 223
6.2 Primary Total Hip Pipeline Products 223
6.2.1 Exactech LPI Prime Hip System 223
6.2.2 EnduRo Bone-preserving Hip Stem 224
6.2.3 Deltamotion Acetabular Cup System 224
6.2.4 NovoSource Hip Implant 225
7 Industry Overview 226
7.1 Procedure Volumes 226
7.1.1 US 227
7.1.2 EU 228
7.1.3 APAC 229
7.1.4 South America 230
7.2 Market Access 231
7.2.1 US 232
7.2.2 EU 235
7.2.3 APAC 237
7.2.4 South America 238
7.3 Reimbursement Trends 239
7.3.1 US 239
7.3.2 Europe 241
7.3.3 Japan 245
7.3.4 South America 246
7.3.5 China 247
7.3.6 India 249
7.4 Regulatory Issues/Recalls 250
7.4.1 DePuy Hip Replacement Recall 250
7.4.2 Stryker Hip Replacement Recall 250
7.4.3 Smith and Nephew Recall: R3 Metal Liners of the R3 Acetabular System 251
7.4.4 Zimmer Durom® Acetabular Component 251
7.4.5 Biomet Hip Replacement Complications 251
7.4.6 Wright Medical Conserve Hip Implant 251
7.4.7 The Corin Group Metal-on-Metal Hip Resurfacing 252
7.5 Mergers and Acquisitions / Key Partnerships 252
7.5.1 Medtronic Acquires China Kanghui Holdings 252
7.5.2 Tornier Acquires OrthoHelix Surgical Designs Inc. 252
7.5.3 DePuy Orthopaedics (Johnson and Johnson) and Synthes Inc. Merge 253
7.5.4 Italian Consortium 2IL Orthopaedics Ltd Acquires Corin Group 253
7.5.5 Zimmer Acquires Beijing Montagne Medical Device Co. Ltd. 253
7.5.6 Wright Medial Announces Agreement to Sell OrthoRecon Business to MicroPort Medical B.V. 254
8 Company Profiles 255
8.1 B. Braun 255
8.1.1 Overview 255
8.1.2 Portfolio Assessment 256
8.1.3 SWOT Analysis 256
8.2 Biomet Orthopedics 257
8.2.1 Overview 257
8.2.2 Portfolio Assessment 258
8.2.3 SWOT Analysis 261
8.3 Corentec Co. Ltd. 262
8.3.1 Overview 262
8.3.2 Portfolio Assessment 262
8.3.3 SWOT Analysis 263
8.4 Corin 263
8.4.1 Overview 263
8.4.2 Portfolio Assessment 264
8.4.3 SWOT Analysis 265
8.5 DePuy Synthes International 266
8.5.1 Overview 266
8.5.2 Portfolio Assessment 267
8.5.3 SWOT Analysis 269
8.6 Exactech 270
8.6.1 Overview 270
8.6.2 Portfolio Assessment 271
8.6.3 SWOT Analysis 272
8.7 Iconacy Orthopedic Implants LLC 273
8.7.1 Overview 273
8.7.2 Portfolio Assessment 273
8.7.3 SWOT Analysis 274
8.8 Implantcast GMBH 274
8.8.1 Overview 274
8.8.2 Portfolio Assessment 274
8.8.3 SWOT Analysis 276
8.9 JRI Orthopaedics 276
8.9.1 Overview 276
8.9.2 Portfolio Assessment 277
8.9.3 SWOT Analysis 278
8.10 Kyocera 278
8.10.1 Overview 278
8.10.2 Portfolio Assessment 279
8.10.3 SWOT Analysis 280
8.11 Limacorporate S.P.A 280
8.11.1 Overview 280
8.11.2 Portfolio Assessment 281
8.11.3 SWOT Analysis 282
8.12 Medacta 283
8.12.1 Overview 283
8.12.2 Portfolio Assessment 283
8.12.3 SWOT Analysis 284
8.13 Medtronic 285
8.13.1 Overview 285
8.13.2 Portfolio Assessment 286
8.13.3 SWOT Analysis 287
8.14 NovoSource Inc. 287
8.14.1 Overview 287
8.14.2 Portfolio Assessment 288
8.14.3 SWOT Analysis 288
8.15 Peter Brehm GMBH 289
8.15.1 Overview 289
8.15.2 Portfolio Assessment 289
8.15.3 SWOT Analysis 290
8.16 Serf Dedienne Sante 290
8.16.1 Overview 290
8.16.2 Portfolio Assessment 291
8.16.3 SWOT Analysis 292
8.17 Smith and Nephew 292
8.17.1 Overview 292
8.17.2 Portfolio Assessment 293
8.17.3 SWOT Analysis 295
8.18 Stelkast 295
8.18.1 Overview 295
8.18.2 Portfolio Assessment 296
8.18.3 SWOT Analysis 296
8.19 Stryker 297
8.19.1 Overview 297
8.19.2 Portfolio Assessment 298
8.19.3 SWOT Analysis 300
8.20 Tianjin Zhengtian Medical Instrument Co., Ltd. 300
8.20.1 Overview 300
8.20.2 Portfolio Assessment 301
8.20.3 SWOT Analysis 301
8.21 Tornier N.V. 302
8.21.1 Overview 302
8.21.2 Portfolio Assessment 303
8.21.3 SWOT Analysis 305
8.22 Wright Medical 305
8.22.1 Overview 305
8.22.2 Portfolio Assessment 306
8.22.3 SWOT Analysis 308
8.23 United Orthopedic Corporation 309
8.23.1 Overview 309
8.23.2 Portfolio Assessment 310
8.23.3 SWOT Analysis 310
8.24 Zimmer Holdings Inc. 311
8.24.1 Overview 311
8.24.2 Portfolio Assessment 312
8.24.3 SWOT Analysis 314
8.25 Other Companies 315
9 Market Drivers, Opportunities and Barriers 316
9.1 Market Drivers 316
9.1.1 Prevalence Rise 316
9.1.2 Expanding Indications 318
9.1.3 Availability and Lack of Long-Term Clinical Data 319
9.1.4 Fracture Incidence 319
9.1.5 Patient Demand and Awareness 320
9.2 Opportunities 320
9.2.1 Revision Surgery 320
9.2.2 Emerging Markets 321
9.2.3 Continued Materials Research 322
9.2.4 Corporate Promotions and Teaching Seminars 322
9.2.5 Advancement towards Cost Reduction 323
9.3 Market Barriers 324
9.3.1 Market Barriers 324
10 Country Outlooks and Forecasts 328
10.1 Major Markets Overview 328
10.2 US Market Analysis 332
10.3 France Market Analysis 335
10.4 Germany Market Analysis 338
10.5 Italy Market Analysis 340
10.6 Spain Market Analysis 341
10.7 UK Market Analysis 343
10.8 Japan Market Analysis 345
10.9 Brazil Market Analysis 347
10.10 China Market Analysis 348
10.11 India Market Analysis 350
11 Appendix 352
11.1 Abbreviations 352
11.2 Bibliography 354
11.3 Report Methodology 372
11.3.1 Overview 372
11.3.2 Coverage 372
11.3.3 Secondary Research 373
11.3.4 Forecasting Methodology 374
11.3.5 Primary Research - Key Opinion Leader Interviews 375
11.3.6 Expert Panel Validation 375
11.4 Physicians and Specialists Included in this Study 376
11.4.1 Dr. Alessandro Aprato 376
11.4.2 Dr. Fran Channa 376
11.4.3 Joseph Daniel FRCS MS (Orth) 376
11.4.4 Dr. Alejandro Gonzalez Della Valle 376
11.4.5 Dr. Moussa Hamadouche 376
11.4.6 Dr. Sheng-Li Huang and Xi-Jing He 376
11.4.7 Dr. Ayumi Kaneuji 376
11.4.8 Dr. Yuichi Mitani 376
11.4.9 Dr. Ning Lu 377
11.4.10 Dr. Deepak Saini 377
11.4.11 Dr. Lafayette Lage 377
11.4.12 Dr. Christoph Zilkens 377
11.5 About the Authors 378
11.5.1 Analysts 378
11.5.2 Global Head of Healthcare 379
11.6 About MediPoint 380
11.7 About GlobalData 380
11.8 Disclaimer 380



List of Tables

Table 1: Clinical Symptoms and Descriptions 40
Table 2: Advantages and Disadvantages of Hip Resurfacing 50
Table 3: Surgical Approaches Comparison 51
Table 4: Global Prevalence of Osteoarthritis in the Major Markets, millions, 2010-2019 56
Table 5: Direct and Indirect Costs of Arthritis 62
Table 6: APAC Product Costs 66
Table 7: Top Five Products Used in the UK, 2003-2011, by Popularity, by Component 71
Table 8: Bicontact Universal Hip System (B. Braun) 74
Table 9: Clinical Studies Bicontact Universal Hip System (B. Braun) 75
Table 10: SWOT Bicontact Universal Hip System 76
Table 11: Excia Hip Stem (B. Braun) 77
Table 12: Clinical Studies Excia Hip Stem (B. Braun) 78
Table 13: SWOT Excia Hip Stem 78
Table 14: Metha® Short Hip Stem (B. Braun) 80
Table 15: Clinical Studies Metha® Short Hip Stem (B. Braun) 81
Table 16: SWOT Metha® Short Hip Stem 81
Table 17: TRJ Cementless Hip Endoprosthesis System (B. Braun) 83
Table 18: SWOT TRJ Cementless Hip Endoprosthesis System 84
Table 19: Plasmacup SC Acetabular Cup (B. Braun) 85
Table 20: Balance Femoral Component (Biomet) 87
Table 21: Clinical Studies Balance Femoral Component (Biomet) 87
Table 22: SWOT Balance Femoral Component 88
Table 23: Bi-Metric Femoral Components (Biomet) 89
Table 24: Clinical Studies Bi-Metric Femoral Components (Biomet) 89
Table 25: SWOT Bi-Metric Femoral Components 90
Table 26: Bio-Moore II Hip System (Biomet) 91
Table 27: Clinical Studies Bio-Moore II Hip System (Biomet) 91
Table 28: SWOT Bio-Moore II Hip System 92
Table 29: Generation 4 Polished Hip System (Biomet) 93
Table 30: SWOT Generation 4 Polished Hip System 93
Table 31: Integral Porous Primary Hip System (Biomet) 94
Table 32: Clinical Studies Integral Porous Hip System (Biomet) 95
Table 33: SWOT Integral Porous Hip System Femoral Components 95
Table 34: Mallory Femoral Component (Biomet) 96
Table 35: Clinical Studies Mallory Femoral Component (Biomet) 97
Table 36: SWOT Mallory Femoral Component 97
Table 37: Progressive Total Hip System (Biomet) 98
Table 38: SWOT Progressive Total Hip System 99
Table 39: Rx 90 Smooth Primary Femoral Component (Biomet) 100
Table 40: SWOT Rx 90 Smooth Primary Femoral Component 100
Table 41: Stanmore Hip System (Biomet) 101
Table 42: Clinical Studies Stanmore Hip System (Biomet) 102
Table 43: SWOT Stanmore Hip System 102
Table 44: Taperloc and Balance Microplasty Hip Stems (Biomet) 103
Table 45: Clinical Studies Taperloc and Balance Microplasty Hip Stems (Biomet) 104
Table 46: SWOT Taperloc and Balance Microplasty Hip Stems 104
Table 47: Acetabular Systems (Biomet) 105
Table 48: Bencox Stems (Corentec Co. Ltd) 106
Table 49: Clinical Studies Bencox Stems (Corentec Co. Ltd) 107
Table 50: SWOT Bencox Stems 107
Table 51: Bencox Acetabular Systems (Corentec Co. Ltd.) 109
Table 52: MetaFix (Corin) 110
Table 53: SWOT MetaFix 110
Table 54: MiniHip (Corin) 112
Table 55: SWOT MiniHip 112
Table 56: MRP-Titan (Corin) 114
Table 57: SWOT MRP-Titan 114
Table 58: TaperFit (Corin) 116
Table 59: SWOT TaperFit 117
Table 60: Trinity Acetabular System (Corin) 118
Table 61: Cenator Acetabular Cup (Corin) 119
Table 62: Cementless Systems (DePuy Synthes) 121
Table 63: Clinical Studies Cementless Systems (DePuy Synthes) 121
Table 64: SWOT DePuy Synthes Cementless Systems 122
Table 65: Cemented Systems (DePuy Synthes) 123
Table 66: Clinical Studies Cemented Systems (DePuy Synthes) 123
Table 67: SWOT DePuy Synthes Cemented Systems 123
Table 68: DePuy Synthes Acetabular Systems (DePuy Synthes) 125
Table 69: AcuMatch Femoral Stems (Exactech) 126
Table 70: Clinical Studies AcuMatch Femoral Stems (Exactech) 126
Table 71: SWOT AcuMatch Femoral Stems 127
Table 72: Novation Femoral Stems (Exactech) 128
Table 73: Clinical Studies Novation Femoral Stems (Exactech) 129
Table 74: SWOT Novation Femoral Stems 129
Table 75: Exactech Acetabular Systems (Exactech) 130
Table 76: i-Hip Total Hip Implant (Iconacy Orthopedic Implants) 132
Table 77: SWOT i-Hip Total Hip Implant 132
Table 78: EcoFit Femoral Stem (Implantcast GMBH) 134
Table 79: Aida Short Femoral Stem (Implantcast GMBH) 135
Table 80: AJS Hip System (Implantcast GMBH) 136
Table 81: DiaLoc Hip Stem (Implantcast GMBH) 137
Table 82: LOAD SHIFT Hip Stem (Implantcast GMBH) 138
Table 83: Ceraco Hip Stem (Implantcast GMBH) 139
Table 84: IC Straight Stem Type I and Type II (Implantcast GMBH) 140
Table 85: Bicana Hip Stem (Implantcast GMBH) 141
Table 86: SWOT Implantcast GMBH Femoral Stems 141
Table 87: Implantcast GMBH Acetabular Cups (Implantcast GMBH) 143
Table 88: Aeon Hip System (JRI Orthopaedics) 144
Table 89: SWOT Aeon Hip System 144
Table 90: Furlong Hip System and Evolution System (JRI Orthopaedics) 145
Table 91: Clinical Studies Furlong Hip System (JRI Orthopaedics) 146
Table 92: SWOT Furlong Hip System and Evolution System 146
Table 93: Limacorporate Cementless Femoral Stems (Limacorporate SPA) 148
Table 94: SWOT Limacorporate Cementless Femoral Stems 148
Table 95: Cemented and Cementless Stems (Limacorporate SPA) 150
Table 96: SWOT Cemented and Cementless Stems (Limacorporate SPA) 150
Table 97: Limacorporate Acetabular Systems 151
Table 98: Cemented and Cementless Stems (Medacta) 153
Table 99: SWOT Medacta Stems 153
Table 100: Acetabular Cups and Femoral Heads (Medacta) 154
Table 101: Helicon Hip System (TGM Medical, wholly owned by Medtronic) 155
Table 102: SWOT Helicon Hip System 155
Table 103: Vektor Titan and Vektor CoCr (Peter Brehm GMBH) 157
Table 104: Clinical Studies Peter Brehm Stems (Peter Brehm GMBH) 157
Table 105: SWOT Peter Brehm Products 158
Table 106: Libra and Sagittal EVL (Serf Dedienne Sante) 160
Table 107: SWOT Libra and Sagittal EVL 160
Table 108: Acetabular Cups (Serf Dedienne Sante) 162
Table 109: Echelon and Synergy (Smith and Nephew) 164
Table 110: SWOT Echelon and Synergy 164
Table 111: Anthology Hip System (Smith and Nephew) 165
Table 112: SWOT Anthology Hip System 166
Table 113: CPCS and Spectron Hip System (Smith and Nephew) 167
Table 114: SWOT CPCS and Spectron Hip System 167
Table 115: Emperion and SMF Modular Stems (Smith and Nephew) 168
Table 116: SWOT Emperion and SMF Modular Stems 169
Table 117: Acetabular Cups (Smith and Nephew) 170
Table 118: ProClass Hip Stem (Stelkast) 171
Table 119: SWOT ProClass Hip Stem 171
Table 120: Progeny Hip Stem (Stelkast) 172
Table 121: SWOT Progeny Hip Stem 173
Table 122: Protract Hip Stem (Stelkast) 174
Table 123: SWOT Protract Hip Stem 174
Table 124: Provident Hip Stem (Stelkast) 175
Table 125: SWOT Provident Hip Stem 176
Table 126: Acetabular Cups (Stelkast) 178
Table 127: Cementless Stems (Stryker) 180
Table 128: SWOT Cementless Stems 180
Table 129: Cemented Stems (Stryker) 181
Table 130: SWOT Cemented Stems 182
Table 131: Acetabular Systems (Stryker) 183
Table 132: Diamond Total Hip Implant (Tianjin Zhengtian Medical Instruments) 184
Table 133: SWOT Diamond Total Hip Implant 184
Table 134: Linea Stem (Tornier N.V.) 186
Table 135: SWOT Linea Stem 187
Table 136: Meije Duo Stem (Tornier N.V.) 188
Table 137: SWOT Meije Duo Stem 189
Table 138: Oceane Stem (Tornier N.V.) 190
Table 139: SWOT Oceane Stem 191
Table 140: Tornier Femoral Heads (Tornier N.V.) 192
Table 141: Oceane Cup (Tornier N.V.) 193
Table 142: Tornier Dynacup (Tornier N.V.) 194
Table 143: Tornier Dual Mobility (Tornier N.V.) 195
Table 144: Perfecta Cementless and Cemented Stems (Wright Medical) 196
Table 145: SWOT Perfecta Cementless and Cemented Stems 197
Table 146: Cementless Femoral Stems (Wright Medical) 199
Table 147: SWOT Cementless Femoral Stems 199
Table 148: Cemented Femoral Stems (Wright Medical) 200
Table 149: SWOT Cemented and Cementless Femoral Stems (Wright Medical) 201
Table 150: Acetabular Systems (Wright Medical) 203
Table 151: UTF and UTF Reduced Stem (United Orthopedic Company) 204
Table 152: SWOT UTF and UTF Reduced Stem 205
Table 153: Hip U1 and U2 Stems (United Orthopedic Corporation) 206
Table 154: SWOT Acetabular Systems (United Orthopedic Corporation) 206
Table 155: Acetabular Systems (United Orthopedic Corporation) 208
Table 156: Press-Fit Stems (Zimmer Holdings Inc.) 210
Table 157: SWOT Press-Fit Stems 210
Table 158: Acetabular Systems (Zimmer Holdings Inc.) 212
Table 159: Exactech LPI Prime Hip System (Exactech) 224
Table 160: Regulatory Differences Between the US and EU 235
Table 161: Company Profile - B. Braun 255
Table 162: B. Braun Product Portfolio 256
Table 163: SWOT Analysis - B. Braun 256
Table 164: Company Profile - Biomet Orthopedics 257
Table 165: Biomet Product Portfolio 259
Table 166: SWOT Analysis - Biomet Orthopedics 261
Table 167: Company Profile - Corentec Co. Ltd. 262
Table 168: Corentec Product Portfolio 262
Table 169: SWOT Analysis - Corentec Co. Ltd. 263
Table 170: Company Profile - Corin Group 264
Table 171: Corin Group Product Portfolio 265
Table 172: SWOT Analysis - Corin Group 265
Table 173: Company Profile - DePuy Synthes International 267
Table 174: DePuy Synthes International Product Portfolio 268
Table 175: SWOT Analysis - DePuy Synthes International 269
Table 176: Company Profile - Exactech 270
Table 177: Exactech Product Portfolio 271
Table 178: SWOT Analysis - Exactech 272
Table 179: Company Profile - Iconacy Orthopedic Implants LLC 273
Table 180: Iconacy Orthopedic Implants LLC Product Portfolio 273
Table 181: SWOT Analysis - Iconacy Orthopedic Implants LLC 274
Table 182: Company Profile - Implantcast GMBH 274
Table 183: Implantcast GMBH Product Portfolio 275
Table 184: SWOT Analysis - Implantcast GMBH 276
Table 185: Company Profile - JRI Orthopaedics 276
Table 186: JRI Orthopaedics Product Portfolio 277
Table 187: SWOT Analysis - JRI Orthopaedics 278
Table 188: Company Profile - KYOCERA Medical Corporation 279
Table 189: KYOCERA Medical Corporation Product Portfolio 279
Table 190: SWOT Analysis - KYOCERA Medical Corporation 280
Table 191: Company Profile - Limacorporate S.P.A 281
Table 192: Limacorporate S.P.A Product Portfolio 281
Table 193: SWOT Analysis - Limacorporate S.P.A 282
Table 194: Company Profile - Medacta International 283
Table 195: Medacta International Product Portfolio 284
Table 196: SWOT Analysis - Medacta International 284
Table 197: Company Profile - Medtronic 285
Table 198: Medtronic Product Portfolio 286
Table 199: SWOT Analysis - Medtronic 287
Table 200: Company Profile - NovoSource Inc. 287
Table 201: NovoSource Inc. Product Portfolio 288
Table 202: SWOT Analysis - NovoSource Inc. 288
Table 203: Company Profile - Peter Brehm GMBH 289
Table 204: Peter Brehm GMBH Product Portfolio 289
Table 205: SWOT Analysis - Peter Brehm GMBH 290
Table 206: Company Profile - Serf Dedienne Sante 290
Table 207: Serf Dedienne Sante Product Portfolio 291
Table 208: SWOT Analysis - Serf Dedienne Sante 292
Table 209: Company Profile - Smith and Nephew 293
Table 210: Smith and Nephew Product Portfolio 294
Table 211: SWOT Analysis - Smith and Nephew 295
Table 212: Company Profile - Stelkast 295
Table 213: Stelkast Product Portfolio 296
Table 214: SWOT Analysis - Stelkast 296
Table 215: Company Profile - Stryker 298
Table 216: Stryker Product Portfolio 299
Table 217: SWOT Analysis - Stryker 300
Table 218: Company Profile - Tianjin Zhengtian Medical Instrument Co. Ltd. 300
Table 219: Tianjin Zhengtian Medical Instrument Co. Ltd. Product Portfolio 301
Table 220: SWOT Analysis - Tianjin Zhengtian Medical Instrument Co. Ltd. 301
Table 221: Company Profile - Tornier N.V. 303
Table 222: Tornier N.V. Product Portfolio 304
Table 223: SWOT Analysis - Tornier N.V. 305
Table 224: Company Profile - Wright Medical 306
Table 225: Wright Medical Product Portfolio 307
Table 226: SWOT Analysis - Wright Medical 308
Table 227: Company Profile - United Orthopedic Corporation 309
Table 228: United Orthopedic Corporation Product Portfolio 310
Table 229: SWOT Analysis - United Orthopedic Corporation 310
Table 230: Company Profile - Zimmer Holdings Inc. 312
Table 231: Zimmer Holdings Inc. Product Portfolio 313
Table 232: SWOT Analysis - Zimmer Holdings, Inc. 314
Table 233: Other Companies in the Global Hip Replacement Market 315
Table 234: Global Sales ($m) Forecast for THR, 2010-2019 328
Table 235: US Sales ($m) Forecast for THR, 2010-2019 334
Table 236: France Sales ($m) Forecast for THR, 2010-2019 337
Table 237: Germany Sales ($m) Forecast for THR, 2010-2019 339
Table 238: Italy Sales ($m) Forecast for THR, 2010-2019 340
Table 239: Spain Sales ($m) Forecast for THR, 2010-2019 342
Table 240: UK Sales ($m) Forecast for THR, 2010-2019 344
Table 241: Japan Sales ($m) Forecast for THR, 2010-2019 346
Table 242: Brazil Sales ($m) Forecast for THR, 2010-2019 347
Table 243: China Sales ($m) Forecast for THR, 2010-2019 349
Table 244: India Sales ($m) Forecast for THR, 2010-2019 351

1.2 List of Figures
Figure 1: Anatomy of the Hip 35
Figure 2: Treatment Paradigm for Hip Osteoarthritis 41
Figure 3: Treatment Paradigm for Hip Fractures 42
Figure 4: Hip Arthrodesis 44
Figure 5: Partial Hip Arthroplasty and Total Hip Arthroplasty 48
Figure 6: Surgical Approach Used by Orthopedic Surgeons Globally 52
Figure 7: Surgical Approach Used by Orthopedic Surgeons in North America 52
Figure 8: Population with Osteoarthritis in the US, 2010-2019 57
Figure 9: Population with Osteoarthritis in the EU, 2010-2019 59
Figure 10: Population with Osteoarthritis in APAC, 2010-2019 60
Figure 11: Population with Osteoarthritis in South America, 2010-2019 61
Figure 12: Costs Related to Total Hip Replacement 64
Figure 13: EU Costs Related to Total Hip Replacement Procedure 65
Figure 14: Global Market Share for Reconstructive Products, 2012 69
Figure 15: US Market Share for Hip Replacement Products, 2010 70
Figure 16: Cementless, Cemented, Hybrid Product Usage by Orthopedic Surgeons, by Country 72
Figure 17: Bicontact Universal Hip System (B. Braun) 73
Figure 18: Excia Hip Stem (B. Braun) 76
Figure 19: Metha® Short Hip Stem (B. Braun) 79
Figure 20: TRJ Cementless Hip Endoprosthesis System (B. Braun) 82
Figure 21: Plasmacup SC Acetabular Cup (B. Braun) 84
Figure 22: Balance Femoral Component (Biomet) 86
Figure 23: Bi-Metric Femoral Components (Biomet) 88
Figure 24: Bio-Moore II Hip System (Biomet) 90
Figure 25: Generation 4 Polished Hip System (Biomet) 92
Figure 26: Integral Porous Primary Hip System (Biomet) 94
Figure 27: Mallory Femoral Component (Biomet) 96
Figure 28: Progressive Total Hip System (Biomet) 98
Figure 29: Rx 90 Smooth Primary Femoral Component (Biomet) 99
Figure 30: Stanmore Hip System (Biomet) 101
Figure 31: Taperloc and Balance Microplasty Hip Stems (Biomet) 103
Figure 32: Bencox Stems (Corentec Co. Ltd) 106
Figure 33: Bencox Acetabular Systems (Corentec Co. Ltd.) 108
Figure 34: MetaFix (Corin) 109
Figure 35: MiniHip (Corin) 111
Figure 36: MRP-Titan (Corin) 113
Figure 37: TaperFit (Corin) 115
Figure 38: Trinity Acetabular System (Corin) 117
Figure 39: Cenator Acetabular Cup (Corin) 119
Figure 40: Cementless Systems (DePuy Synthes) 120
Figure 41: Cemented Systems (DePuy Synthes) 122
Figure 42: DePuy Acetabular Systems (DePuy Synthes) 124
Figure 43: AcuMatch Femoral Stems (Exactech) 125
Figure 44: Novation Femoral Stems (Exactech) 127
Figure 45: i-Hip Total Hip Implant (Iconacy Orthopedic Implants) 131
Figure 46: EcoFit Femoral Stem (Implantcast GMBH) 133
Figure 47: Aida Short Femoral Stem (Implantcast GMBH) 134
Figure 48: AJS Hip System (Implantcast GMBH) 135
Figure 49: DiaLoc Hip Stem (Implantcast GMBH) 136
Figure 50: LOAD SHIFT Hip Stem (Implantcast GMBH) 137
Figure 51: Ceraco Hip Stem (Implantcast GMBH) 138
Figure 52: IC Straight Stem Type I and Type II (Implantcast GMBH) 139
Figure 53: Bicana Hip Stem (Implantcast GMBH) 140
Figure 54: Implantcast GMBH Acetabular Cups (Implantcast GMBH) 142
Figure 55: Aeon Hip System (JRI Orthopaedics) 143
Figure 56: Furlong Hip System and Evolution System (JRI Orthopaedics) 145
Figure 57: Cemented and Cementless Stems (Limacorporate SPA) 149
Figure 58: Cemented and Cementless Stems (Medacta) 152
Figure 59: Helicon Hip System (TGM Medical wholly owned by Medtronic) 154
Figure 60: Vektor-Titan and Vektor-CoCr (Peter Brehm GMBH) 156
Figure 61: Libra and Sagitta EVL (Serf Dedienne Sante) 159
Figure 62: Acetabular Cups (Serf Dedienne Sante) 161
Figure 63: Echelon and Synergy (Smith and Nephew) 163
Figure 64: Anthology Hip System (Smith and Nephew) 165
Figure 65: CPCS and Spectron Hip System (Smith and Nephew) 166
Figure 66: Emperion and SMF Modular Stems (Smith and Nephew) 168
Figure 67: Acetabular Cups (Smith and Nephew) 169
Figure 68: ProClass Hip Stem (Stelkast) 170
Figure 69: Progeny Hip Stem (Stelkast) 172
Figure 70: Protract Hip Stem (Stelkast) 173
Figure 71: Provident Hip Stem (Stelkast) 175
Figure 72: Acetabular Systems (Stelkast) 177
Figure 73: Cementless Stems (Stryker) 179
Figure 74: Cemented Stems (Stryker) 181
Figure 75: Acetabular Systems (Stryker) 182
Figure 76: Diamond Total Hip Implant (Tianjin Zhengtian Medical Instruments) 183
Figure 77: Linea Stem (Tornier N.V.) 185
Figure 78: Meije Duo Stem (Tornier N.V.) 187
Figure 79: Oceane Stem (Tornier N.V.) 189
Figure 80: Tornier Femoral Heads (Tornier N.V.) 191
Figure 81: Oceane Cup (Tornier N.V.) 192
Figure 82: Tornier Dynacup (Tornier N.V.) 194
Figure 83: Tornier Dual Mobility (Tornier N.V.) 195
Figure 84: Perfecta Cementless and Cemented Stems (Wright Medical) 196
Figure 85: Cementless Femoral Stems (Wright Medical) 198
Figure 86: Profemur Gladiator (Wright Medical) 200
Figure 87: Acetabular Systems (Wright Medical) 202
Figure 88: UTF and UTF Reduced Stem (United Orthopedic Corporation) 204
Figure 89: Hip U1 and U2 Stems (United Orthopedic Corporation) 205
Figure 90: Acetabular Systems (United Orthopedic Corporation) 207
Figure 91: Press-Fit Stems (Zimmer Holdings Inc.) 209
Figure 92: Acetabular Systems (Zimmer Holdings Inc.) 211
Figure 93: US Primary Hip Arthroplasty Procedure Volumes (2010-2019) 228
Figure 94: Europe Primary Hip Arthroplasty Procedure Volumes (2010-2019) 229
Figure 95: Asia-Pacific Primary Hip Arthroplasty Procedure Volumes (2010-2019) 230
Figure 96: South America Primary Hip Arthroplasty Procedure Volumes (2010-2019) 231
Figure 97: Arthroplasty Cost Breakdown With Patient Discharged Home (2007) 233
Figure 98: Medicare Payment Trend for Hip and Knee Joint Replacement, 1985-2009 240
Figure 99: Global Sales ($m) Forecast for THR, 2010-2019 329
Figure 100: THR Revenue by Major Market, 2012 and 2019 330
Figure 101: THR Revision Surgery Revenue by Major Market, 2012 and 2019 331
Figure 102: US Sales ($m) Forecast for THR, 2010-2019 335
Figure 103: France Sales ($m) Forecast for THR, 2010-2019 338
Figure 104: Germany Sales ($m) Forecast for THR, 2010-2019 339
Figure 105: Italy Sales ($m) Forecast for THR, 2010-2019 341
Figure 106: Spain Sales ($m) Forecast for THR, 2010-2019 343
Figure 107: UK Sales ($m) Forecast for THR, 2010-2019 345
Figure 108: Japan Sales ($m) Forecast for THR, 2010-2019 346
Figure 109: Brazil Sales ($m) Forecast for THR, 2010-2019 348
Figure 110: China Sales ($m) Forecast for THR, 2010-2019 349
Figure 111: India Sales ($m) Forecast for THR, 2010-2019 351



Companies Mentioned

B. Braun
Biomet Orthopedics
Corentec Co. Ltd.
Corin
DePuy Synthes International
Exactech
Iconacy Orthopedic Implants LLC
Implantcast GMBH
JRI Orthopaedics
Kyocera
Limacorporate S.P.A
Medacta
Medtronic
NovoSource Inc.
Peter Brehm GMBH
Serf Dedienne Sante
Smith and Nephew
Stelkast
Stryker
Tianjin Zhengtian Medical Instrument Co., Ltd.
Tornier N.V.
Wright Medical
United Orthopedic Corporation
Zimmer Holdings Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Orthopedics Market 2014: Strategic Assessments of  Leading Suppliers

Future Horizons and Growth Strategies in the Global Orthopedics Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,900. A strategic assessment of the competitive environment is unquestionably one of the highest priority management responsibilities, the task ...

Joint Reconstruction and Replacement: Materials, Technologies, and Global Markets

Joint Reconstruction and Replacement: Materials, Technologies, and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report covers the global joint reconstruction and replacement market, procedures, key growth areas, and quantitative market projections for technologies and devices through 2018. Increasing ...

MediPoint: Spinal Fusion - Global Analysis and Market Forecasts

MediPoint: Spinal Fusion - Global Analysis and Market Forecasts

  • $ 6 495
  • Industry report
  • June 2014
  • by Global Data

MediPoint: Spinal Fusion - Global Analysis and Market Forecasts Summary Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.